Clarus appoints chief commercial officer
This article was originally published in Scrip
Executive Summary
Northbrook, Illinois-based Clarus Therapeutics, which specializes in men's health, has named Patrick Shea chief commercial officer. Prior to joining the company which is developing oral testosterone replacement product Rextoro, Mr Shea was vice-president of sales and marketing at CSL Behring (US operations). He will report directly to Clarus' president and CEO Dr Robert E Dudley.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.